Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "We forecast flat IP revenues from IP licensing."

Hm, if we don't expect growing revenues in the next years, I don't see any chances to make some big steps with mergers & acquisitions. So I suspect, we won't see even the pessimistic numbers of the Cohen Report:

"Our single point short-term price target based on our Optimistic, Base Case and Pessimistic scenarios is

$0.86, $0.63, and $0.48, respectively. "

I'd like to have some easter surprises in my bag in the next days...;-))

Share
New Message
Please login to post a reply